Effect of Extraction Methods and In Vitro Bio-Accessibility of Microencapsulated Lemon Extract.

The extraction of bioactive compounds from fruits, such as lemon, has gained relevance because these compounds have beneficial properties for health, such as antioxidant and anticancer properties; however, the extraction method can significantly affect these properties. High hydrostatic pressure and ultrasound, as emerging extraction methods, constitute an alternative to conventional extraction, improving extractability and obtaining extracts rich in bioactive compounds. Therefore, lemon extracts (LEs) were obtained by conventional (orbital shaking), ultrasound-assisted, and high-hydrostatic-pressure extraction. Extracts were then microencapsulated with maltodextrin at 10% (M10), 20% (M20), and 30% (M30). The impact of microencapsulation on LEs physicochemical properties, phenolics (TPC), flavonoids (TFC) and relative bio-accessibility (RB) was evaluated. M30 promoted a higher microencapsulation efficiency for TPC and TFC, and a longer time required for microcapsules to dissolve in water, as moisture content, water activity and hygroscopicity decreased. The RBs of TPC and TFC were higher in microcapsules with M30, and lower when conventional extraction was used. The data suggest that microencapsulated LE is promising as it protects the bioactivity of phenolic compounds. In addition, this freeze-dried product can be utilized as a functional ingredient for food or supplement formulations.

Single ventricle palliation of truncus arteriosus with mitral atresia, interrupted aortic arch, and aberrant right subclavian artery.

The association of truncus arteriosus communis with interrupted aortic arch and mitral atresia is an exceptionally rare congenital defect. We describe the initial decision-making and management of this lesion, which eventually achieved a Fontan palliation.

Ruthenium Complex Induce Cell Death in G-415 Gallbladder Cancer Cells.

PURPOSE: In this work, we present a recently developed ruthenium complex that shows anticancer activity in gallbladder cancer cells. METHODS: After the synthesis of the new ruthenium complexes, the antiproliferative, cytotoxicity, and apoptosis activities were evaluated in vitro by the triple assay ApoTox-Glo. Then, the transcription levels of genes related to apoptosis were evaluated by real-time PCR (q-PCR). RESULTS: The ruthenium complex, called Ru-UCN3, inhibits the proliferation of gallbladder cancer cells G-415 by means of apoptosis, which was demonstrated by the overexpression of the pro-apoptotic genes Puma, Diablo, and Caspasa-9 together with the repression of the anti-apoptotic genes Bcl-xL and Bcl-2. In addition, we found strong caspase 3/7 activity in the cells at 24 h of the Ru-UCN3 exposure, which was evaluated by the triple ApoTox-Glo assay. CONCLUSION: The new ruthenium complexes evaluated had an inhibitory effect on G-415 cells. We think that Ru-UCN3 could be a promising anticancer agent, which should be explored with more in vitro and in vivo assays and probably with the chemical modulation of this molecule.

Effect of pH in the photoluminescence of a ruthenium complex featuring a derivative of the ligand pyrazine[2,3-f][1,10]-phenanthroline.

A new ruthenium complex, [Ru(bpy)2(dbe-ppl)](PF6)2 (bpy=2,2'-bipyridine and dbe-ppl=dimethyl 4,4'-(pyrazino[2,3-f][1,10]phenanthroline-2,3-diyl)dibenzoate, has been synthesized and characterized by (1)H NMR spectroscopy, UV-Vis, IR, and cyclic voltammetry. Irradiation on the MLCT band results in photoluminescence in both protic and aprotic solvents. The photoluminescence in water is pH dependent, it shows a behavior which can be described by the Henderson-Hasselbalch assuming the protonation/deprotonation of the excited state with a pKa of 2.40±0.01.